Unicycive Therapeutics, Inc. (UNCY)
NASDAQ: UNCY · Real-Time Price · USD
7.11
-0.06 (-0.84%)
Apr 29, 2026, 9:38 AM EDT - Market open
Unicycive Therapeutics Market Cap
Unicycive Therapeutics has a market cap or net worth of $179.44 million as of April 29, 2026. Its market cap has increased by 173.74% in one year.
Market Cap
179.44M
Enterprise Value
139.80M
1-Year Change
173.74%
Ranking
Category
Stock Price
$7.11
Market Cap Chart
Since the IPO on July 13, 2021, Unicycive Therapeutics's market cap has increased from $66.49M to $179.44M, an increase of 169.88%. That is a compound annual growth rate of 23.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 180.95M | 45.93% |
| Dec 31, 2025 | 124.01M | 50.43% |
| Dec 31, 2024 | 82.44M | 173.36% |
| Dec 29, 2023 | 30.16M | 270.11% |
| Dec 30, 2022 | 8.15M | -73.58% |
| Dec 31, 2021 | 30.84M | -53.61% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MacroGenics | 191.32M |
| Humacyte | 188.16M |
| Canton Strategic Holdings | 186.97M |
| Korro Bio | 184.61M |
| Precision BioSciences | 183.20M |
| Tonix Pharmaceuticals Holding | 180.55M |
| Cartesian Therapeutics | 180.26M |
| Acumen Pharmaceuticals | 177.64M |